Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia.

Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not clear to which extent comorbidities contribute to this effect. The objective of this study was to determine the impact of pretreatment comorbidities on survival of AML patients. In a single-center retrospectiv...

Full description

Bibliographic Details
Main Authors: Maxi Wass, Friederike Hitz, Judith Schaffrath, Carsten Müller-Tidow, Lutz P Müller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5061362?pdf=render

Similar Items